Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer.

Cite this paper

@article{Rivera2008Phase3S, title={Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer.}, author={E. M. Rivera and Jaime A Mejia and Banu K. Arun and Rosnie B Adinin and Ronald Stewart Walters and Abenaa Brewster and Kristine R. Broglio and Guosheng Yin and Bita Esmaeli and Gabriel N Hortobagyi and Vicente Valero}, journal={Cancer}, year={2008}, volume={112 7}, pages={1455-61} }